CoChat

DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease

Open access
Olkhanud, Purevdorj B., Mughal, Mohammed, Ayukawa, Koichi, Malchinkhuu, Enkhzol, Bodogai, Monica, Feldman, Neil, Rothman, Sarah, Lee, Jong-Hwan, Chigurupati, Srinivasulu, Okun, Eitan, Nagashima, Kunio, Mattson, Mark P., Biragyn, Arya · 2012 · Vaccine
Cited by 24

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is an incurable and progressive neurodegenerative senile disorder associated with the brain accumulation of Aβ plaques. Although vaccines that reduce Aβ plaques can control AD, the rationale for their use at the onset of the disease remains debatable. Old humans and mice usually respond poorly to vaccines due to presumably age-related immunological impairments. Here, we report that by modifying vaccines, the poor responsiveness of old mice can be reversed. Unlike the Aβ peptide vaccine, DNA immunizations with the amino-terminal Aβ(1-11) fragment exposed on the surface of HBsAg particles elicit high levels of anti-Aβ antibody both in young and old mice. Importantly, in AD model 3xTgAD mice, the vaccine reduced Aβ plaques, ameliorated cognitive impairments and, surprisingly, significantly increased life span. Hence, we propose that vaccines targeting Aβ(1-11) can efficiently combat AD-induced pathological alterations and provide survival benefit in patients with AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2011.12.136

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 24

Metadata

Authors
Olkhanud, P. B., Mughal, M., Ayukawa, K., Malchinkhuu, E., Bodogai, M., Feldman, N., Rothman, S., Lee, J.-H., Chigurupati, S., Okun, E., Nagashima, K., Mattson, M. P., & Biragyn, A.
Venue
Vaccine
Publisher
Elsevier BV
Published
2012-02
Volume
30
Issue
9
Pages
1650-1658
ISSN
0264-410X (ISSN-L)
OpenAlex
W2053553825
Cited by
24
References
14
FWCI
1.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.vaccine.2011.12.136
The paper
Olkhanud, P. B., Mughal, M., Ayukawa, K., Malchinkhuu, E., Bodogai, M., Feldman, N., Rothman, S., Lee, J.-H., Chigurupati, S., Okun, E., Nagashima, K., Mattson, M. P., & Biragyn, A. (2012). DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease. Vaccine. https://doi.org/10.1016/j.vaccine.2011.12.136

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.